Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.14797/mdcj-16-3-241 http://scihub22266oqcxt.onion/10.14797/mdcj-16-3-241 33133361!7587309!33133361     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Methodist+Debakey+Cardiovasc+J 2020 ; 16 (3): 241-244 Nephropedia Template TP {{tp|p=33133361|t=2020. BRASH Syndrome with Hyperkalemia: An Under-Recognized Clinical Condition |pdf=|usr=}}{{33133361}} gab.com Text BRASH Syndrome with Hyperkalemia: An Under-Recognized Clinical Condition JO: Methodist Debakey Cardiovasc J http://www.kidney.de/pget.php?&tw=1&pmid=33133361 #FOAvip BRASH syndrome is characterized by bradycardia, renal failure, use of an atrioventricular nodal blocker (AVNB), shock, and hyperkalemia. These symptoms represent an ongoing vicious cycle in a patient with a low glomerular filtration rate taking an AVNB. Decreased clearance of the medication and hyperkalemia associated with renal failure synergize to cause bradycardia and hypoperfusion. This reaction causes renal function to worsen, thereby perpetuating the cycle of BRASH syndrome. Twit Text FOAVip BRASH Syndrome with Hyperkalemia: An Under-Recognized Clinical Condition ????Methodist Debakey Cardiovasc J http://www.kidney.de/pget.php?&tw=1&pmid=33133361 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33133361 #FOAvip English Wikipedia <ref>{{Cite pmid|33133361}}</ref> BRASH Syndrome with Hyperkalemia: An Under-Recognized Clinical Condition #MMPMID33133361 Arif AW; Khan MS; Masri A; Mba B; Talha Ayub M; Doukky R Methodist Debakey Cardiovasc J 2020[Jul]; 16 (3): 241-244 PMID33133361show ga BRASH syndrome is characterized by bradycardia, renal failure, use of an atrioventricular nodal blocker (AVNB), shock, and hyperkalemia. These symptoms represent an ongoing vicious cycle in a patient with a low glomerular filtration rate taking an AVNB. Decreased clearance of the medication and hyperkalemia associated with renal failure synergize to cause bradycardia and hypoperfusion. This reaction causes renal function to worsen, thereby perpetuating the cycle of BRASH syndrome. |Antihypertensive Agents/*adverse effects[MESH] |Atrioventricular Node/*drug effects/physiopathology[MESH] |Bradycardia/*chemically induced/diagnosis/physiopathology/therapy[MESH] |Diltiazem/*adverse effects[MESH] |Female[MESH] |Glomerular Filtration Rate[MESH] |Humans[MESH] |Hyperkalemia/diagnosis/*etiology/physiopathology/therapy[MESH] |Kidney/physiopathology[MESH] |Middle Aged[MESH] |Renal Insufficiency, Chronic/*complications/diagnosis/therapy[MESH] |Syndrome[MESH]BRASH Syndrome with Hyperkalemia: An Under-Recognized Clinical Conditi(epmc).pdf DeepDyve Pubget Overpricing